APY Ventures

APY Ventures is an Istanbul-based active investor focusing on deep tech and Industry 4.0 innovations in the Turkish ecosystem. Check sizes of $250k to $1M and a stage range from pre-seed through Series A reflect early-stage participation. Healthcare exposure spans digital health and deep tech, with explicit AI thematic positioning.

The firm’s natural fit is with Turkish technical founders building deep tech, Industry 4.0, or AI-enabled software products, including healthcare applications such as AI-enabled diagnostics, connected medical devices, and clinical workflow automation. The right founder profile is a technical team with credible engineering depth, often with academic or research roots in Turkish technical universities. Founders building DTC consumer health, biotech with multi-year preclinical timelines, or pure US-market software without Turkish ties are not the natural target.

Geographically, APY’s advantage is the Turkish deep tech and Industry 4.0 ecosystem, including Istanbul’s growing density of technical talent and corporate R&D. The firm has connectivity to regional Turkish follow-on capital and to European deep tech investors interested in Turkish deal flow. For Turkish-anchored founders, the firm is a credible early partner. For non-Turkish founders, the strategic logic is thin.

The right entry path is a warm intro from a portfolio founder, a Turkish technical university research office, or a regional Turkish VC. The firm reads partner-led decks and responds to clear deep tech or Industry 4.0 theses with credible technical depth. The pitch should lead with the technical or scientific moat, the founder team’s credibility, the development timeline, and a credible regulatory and commercial plan. AI narrative should connect to specific outcomes.

Caveats. Turkish fund structures and FX dynamics complicate cross-border rounds; engage experienced regional counsel. The firm’s healthcare-specific portfolio depth is not as concentrated as that of dedicated deep tech health funds; reference calls with portfolio founders are advisable. The check size is moderate; for founders raising larger seeds, APY should be a participant alongside a real lead. For Turkish technical founders building deep tech with healthcare applications, APY Ventures is a credible early specialist partner; for founders without Turkish ties or technical depth, the fit is weaker.